News

Recent news and press releases

Kiox raise 2.2m dkk to continue development of treatments for rare lung diseases 9. februar 2024 - With the investment Kiox will finalise product development on KX01 before moving into clinical trials. We have further strengthened our pipeline with another inhaled therapy (KX03) that now enters pre-clinical development.
Innovation Fund Denmark awards Kiox grant for research in interstitial lung diseases 12. juni 2023 - Kiox is accepted into the Innobooster program by Innovation Fund Denmark. The grant will fund development of a new treatments for interstitial lung disases.
Kiox partners with Iconovo to develop inhaled treatments for rare lung diseases 9. juni 2023 - Iconovo is a leading inhalation formulation and device company based in Lund, Sweden. Kiox andIconovo will work on developing inhaled treatment for rare lung diseases.